abstract |
Provision of a medicine comprising a combination of a HER2 inhibitor and a hormone therapy agent or an anticancer agent. (1) A pharmaceutical comprising a combination of a HER2 inhibitor having a pyrrolopyrimidine skeleton or a pyrazolopyrimidine skeleton, and (2) a hormone therapy agent or an anticancer agent. [Selection figure] None |